scholarly article | Q13442814 |
P50 | author | Suzanne Oparil | Q30029225 |
Anthony J Viera | Q41172215 | ||
Keith M Diaz | Q84372625 | ||
Meredith Kilgore | Q88244081 | ||
Paul Muntner | Q90572515 | ||
Daichi Shimbo | Q98526959 | ||
Shia T Kent | Q114414594 | ||
P2093 | author name string | Lei Huang | |
P2860 | cites work | Measuring diagnoses: ICD code accuracy | Q24537540 |
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 | ||
Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data | Q30926045 | ||
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. | Q34051241 | ||
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone | Q34123137 | ||
Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care? | Q34224324 | ||
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association | Q34338939 | ||
Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study | Q35129492 | ||
Hospital characteristics related to the intention to apply for meaningful use incentive payments | Q35896593 | ||
Ambulatory blood-pressure monitoring | Q36493993 | ||
Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population | Q36713745 | ||
Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis | Q37339098 | ||
Cost-effectiveness of secondary screening modalities for hypertension | Q37651806 | ||
Resistant hypertension: a review of diagnosis and management. | Q38217294 | ||
Hospital IT adoption strategies associated with implementation success: implications for achieving meaningful use. | Q39861750 | ||
Use of electronic health records in U.S. hospitals | Q39879070 | ||
When and how to use self (home) and ambulatory blood pressure monitoring | Q39881998 | ||
Cost-effectiveness of ambulatory blood pressure: a reanalysis | Q40365892 | ||
Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacy | Q42693608 | ||
White coat effect and its clinical implications in the elderly | Q43265554 | ||
Management of hypertension: summary of NICE guidance | Q46608322 | ||
Three payer strategies to increase revenue | Q47751309 | ||
Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. | Q51458089 | ||
Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati | Q51542873 | ||
Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. | Q53096907 | ||
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring | Q57085349 | ||
Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators | Q57085832 | ||
Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice | Q74300159 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 898-908 | |
P577 | publication date | 2014-10-02 | |
P1433 | published in | Journal of the American Society of Hypertension | Q15816756 |
P1476 | title | Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries | |
P478 | volume | 8 |
Q40112225 | Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States |
Q57787236 | Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both? |
Q50194085 | Implementing ABPM into Clinical Practice |
Q46922060 | Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i |
Q38966241 | Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension |
Q58121798 | Number of Measurements Needed to Obtain a Reliable Estimate of Home Blood Pressure: Results From the Improving the Detection of Hypertension Study |
Q28073632 | Practical Aspects of Home and Ambulatory Blood Pressure Monitoring |
Q36264027 | Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review |
Q36913602 | Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication |
Search more.